SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C - Offering Statement:
SEC Accession No. 0001670254-21-001105
Filing Date
2021-10-01
Accepted
2021-10-01 17:21:19
Documents
13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11425
2 document_1.pdf EX-99 8307627
3 document_2.pdf EX-99 2803713
4 document_3.pdf EX-99 106697
5 document_4.pdf EX-99 9255207
6 document_5.pdf EX-99 19346370
7 document_6.pdf EX-99 9255305
8 document_7.pdf EX-99 19346052
9 document_8.pdf EX-99 20008689
10 document_9.pdf EX-99 9228601
11 document_10.pdf EX-99 413847
12 document_11.pdf EX-99 4996390
13 documents_list.htm EX-99 123
  Complete submission text file 0001670254-21-001105.txt   139767431
Mailing Address 3-E GILL STREET WOBURN MA 01801
Business Address 3-E GILL STREET WOBURN MA 01801 7819326933
Aphios Pharma LLC (Filer) CIK: 0001750795 (see all company filings)

IRS No.: 820903443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-28896 | Film No.: 211300016